Advertisement
COO vs TRIB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongBuy and TRIB is a Hold.
Momentum Indicator for COO turns positive, indicating new upward trend
COO saw its Momentum Indicator move above the 0 level on October 16, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In 52 of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at 58%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for COO just turned positive on September 25, 2026. Looking at past instances where COO's MACD turned positive, the stock continued to rise in 21 of 41 cases over the following month. The odds of a continued upward trend are 51%.
Following a +2.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in 152 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 116 of 222 cases where COO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
Bearish Trend Analysis
The 10-day RSI Indicator for COO moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 14 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 62 cases where COO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
COO broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.360) is normal, around the industry mean (4.882). P/E Ratio (20.324) is within average values for comparable stocks, (38.076). Projected Growth (PEG Ratio) (0.532) is also within normal values, averaging (4.143). Dividend Yield (0.001) settles around the average of (0.005) among similar stocks. P/S Ratio (2.526) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. COO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Momentum Indicator for TRIB turns negative, indicating new downward trend
TRIB saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 89 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 50-day moving average for TRIB moved below the 200-day moving average on September 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRIB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
TRIB broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TRIB entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TRIB's RSI Oscillator exited the oversold zone, 37 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +29.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRIB advanced for three days, in 169 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.071) is normal, around the industry mean (4.209). P/E Ratio (-0.105) is within average values for comparable stocks, (1.433). Projected Growth (PEG Ratio) (0.329) is also within normal values, averaging (11.253). TRIB's Dividend Yield (0.698) is considerably higher than the industry average of (0.010). P/S Ratio (0.131) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. TRIB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
COO | TRIB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 59 Fair valued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 100 | |
PRICE GROWTH RATING 1..100 | 59 | 85 | |
P/E GROWTH RATING 1..100 | 84 | 14 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TRIB's Valuation (2) in the Medical Specialties industry is somewhat better than the same rating for COO (59). This means that TRIB’s stock grew somewhat faster than COO’s over the last 12 months.
TRIB's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as COO (100). This means that TRIB’s stock grew similarly to COO’s over the last 12 months.
COO's SMR Rating (80) in the Medical Specialties industry is in the same range as TRIB (100). This means that COO’s stock grew similarly to TRIB’s over the last 12 months.
COO's Price Growth Rating (59) in the Medical Specialties industry is in the same range as TRIB (85). This means that COO’s stock grew similarly to TRIB’s over the last 12 months.
TRIB's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for COO (84). This means that TRIB’s stock grew significantly faster than COO’s over the last 12 months.
| COO | TRIB | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 50% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 58% | 2 days ago 90% |
| MACD ODDS (%) | 5 days ago 51% | N/A |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 52% | 2 days ago 90% |
| Advances ODDS (%) | 12 days ago 56% | 16 days ago 82% |
| Declines ODDS (%) | 4 days ago 60% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 58% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 52% | 2 days ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COO’s FA Score shows that 0 FA rating(s) are green while TRIB’s FA Score has 2 green FA rating(s).
- COO’s FA Score: 0 green, 5 red.
- TRIB’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COO’s TA Score shows that 4 TA indicator(s) are bullish while TRIB’s TA Score has 3 bullish TA indicator(s).
- COO’s TA Score: 4 bullish, 4 bearish.
- TRIB’s TA Score: 3 bullish, 5 bearish.
Price Growth
COO (@Pharmaceuticals: Other) experienced а -2.71% price change this week, while TRIB (@Medical/Nursing Services) price change was -13.82% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.77%. For the same industry, the average monthly price growth was -3.29%, and the average quarterly price growth was +8.60%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.04%. For the same industry, the average monthly price growth was -8.74%, and the average quarterly price growth was -9.59%.
Reported Earning Dates
COO is expected to report earnings on Dec 03, 2026.
TRIB is expected to report earnings on Dec 22, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-1.77% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+0.04% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
COO and
Correlation & Price change
A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.
TRIB and
Correlation & Price change
A.I.dvisor tells us that TRIB and RGEN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and RGEN's prices will move in lockstep.
| Ticker / NAME | Correlation To TRIB | 1D Price Change % | ||
|---|---|---|---|---|
| TRIB | 100% | -3.08% | ||
| RGEN - TRIB | 28% Poorly correlated | -6.20% | ||
| NVCR - TRIB | 26% Poorly correlated | +0.31% | ||
| SERA - TRIB | 23% Poorly correlated | -0.97% | ||
| COO - TRIB | 23% Poorly correlated | -1.31% | ||
| CODX - TRIB | 23% Poorly correlated | -7.16% | ||
More | ||||